Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 92

1.

Assembly dynamics of PML nuclear bodies in living cells.

Brand P, Lenser T, Hemmerich P.

PMC Biophys. 2010 Mar 5;3(1):3. doi: 10.1186/1757-5036-3-3.

2.

Dynamics of component exchange at PML nuclear bodies.

Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G, Hoischen C, Maul G, Dittrich P, Hemmerich P.

J Cell Sci. 2008 Aug 15;121(Pt 16):2731-43. doi: 10.1242/jcs.031922. Epub 2008 Jul 29.

3.

C-terminal motifs in promyelocytic leukemia protein isoforms critically regulate PML nuclear body formation.

Li C, Peng Q, Wan X, Sun H, Tang J.

J Cell Sci. 2017 Oct 15;130(20):3496-3506. doi: 10.1242/jcs.202879. Epub 2017 Aug 29.

4.

Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Geng Y, Monajembashi S, Shao A, Cui D, He W, Chen Z, Hemmerich P, Tang J.

J Biol Chem. 2012 Aug 31;287(36):30729-42. doi: 10.1074/jbc.M112.374769. Epub 2012 Jul 7.

5.

Multimodal Light Microscopy Approaches to Reveal Structural and Functional Properties of Promyelocytic Leukemia Nuclear Bodies.

Hoischen C, Monajembashi S, Weisshart K, Hemmerich P.

Front Oncol. 2018 May 25;8:125. doi: 10.3389/fonc.2018.00125. eCollection 2018. Review.

6.

Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.

Maroui MA, Pampin M, Chelbi-Alix MK.

J Virol. 2011 Dec;85(24):13164-73. doi: 10.1128/JVI.05808-11. Epub 2011 Oct 12.

7.

The functional roles of PML nuclear bodies in genome maintenance.

Chang HR, Munkhjargal A, Kim MJ, Park SY, Jung E, Ryu JH, Yang Y, Lim JS, Kim Y.

Mutat Res. 2018 May;809:99-107. doi: 10.1016/j.mrfmmm.2017.05.002. Epub 2017 May 5. Review.

PMID:
28521962
8.

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.

Bernardi R, Pandolfi PP.

Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16. Review.

PMID:
17928811
9.

Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.

Bøe SO, Haave M, Jul-Larsen A, Grudic A, Bjerkvig R, Lønning PE.

J Cell Sci. 2006 Aug 15;119(Pt 16):3284-95. Epub 2006 Jul 25.

11.

Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.

Herzer K, Weyer S, Krammer PH, Galle PR, Hofmann TG.

Cancer Res. 2005 Dec 1;65(23):10830-7.

12.

Role and fate of PML nuclear bodies in response to interferon and viral infections.

Regad T, Chelbi-Alix MK.

Oncogene. 2001 Oct 29;20(49):7274-86. Review.

13.

Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.

Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, Niwa-Kawakita M, Faklaris O, Setterblad N, de Thé H, Lallemand-Breitenbach V.

J Cell Biol. 2014 Mar 17;204(6):931-45. doi: 10.1083/jcb.201305148.

14.

PML nuclear bodies as sites of epigenetic regulation.

Torok D, Ching RW, Bazett-Jones DP.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1325-36. Review.

PMID:
19273133
15.

KAP1 depletion increases PML nuclear body number in concert with ultrastructural changes in chromatin.

Kepkay R, Attwood KM, Ziv Y, Shiloh Y, Dellaire G.

Cell Cycle. 2011 Jan 15;10(2):308-22. Epub 2011 Jan 15.

PMID:
21228624
16.

Nuclear bodies and compartments: functional roles and cellular signalling in health and disease.

Zimber A, Nguyen QD, Gespach C.

Cell Signal. 2004 Oct;16(10):1085-104. Review.

PMID:
15240004
17.

Surface residue mutations of the PML RING finger domain alter the formation of nuclear matrix-associated PML bodies.

Boddy MN, Duprez E, Borden KL, Freemont PS.

J Cell Sci. 1997 Sep;110 ( Pt 18):2197-205.

18.

Role of nuclear bodies in apoptosis signalling.

Krieghoff-Henning E, Hofmann TG.

Biochim Biophys Acta. 2008 Nov;1783(11):2185-94. doi: 10.1016/j.bbamcr.2008.07.002. Epub 2008 Jul 16. Review.

19.

Subcellular distribution of nuclear import-defective isoforms of the promyelocytic leukemia protein.

Jul-Larsen A, Grudic A, Bjerkvig R, Bøe SO.

BMC Mol Biol. 2010 Nov 21;11:89. doi: 10.1186/1471-2199-11-89.

20.

β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.

Satow R, Shitashige M, Jigami T, Fukami K, Honda K, Kitabayashi I, Yamada T.

Gastroenterology. 2012 Mar;142(3):572-81. doi: 10.1053/j.gastro.2011.11.041. Epub 2011 Dec 9.

PMID:
22155184

Supplemental Content

Support Center